Abstract

BackgroundAn increasing prevalence of having survived a myocardial infarction increases the importance of medical secondary prevention. Although preventive medication reduces mortality, prescribing and adherence are known to be frequently insufficient. General practitioners are the most important prescriber. However, their perspective on prescribing and medical non-adherence following myocardial infarction has not yet been explored. Thus, the aim of this study was to explore the general practitioners’ perspective on long-term care after myocardial infarction focussing on medical prevention.MethodsIn this qualitative interview study we conducted episodic interviews with sixteen general practitioners from rural and urban surgeries in Germany. Framework analysis with focus on general practitioners’ prescribing and patients’ non-adherence was performed.ResultsAlmost all general practitioners reported following guidelines for myocardial infarction aftercare and prescribing the medication that was initiated in the hospital; however, they described deviating from guidelines because of drugs’ side effects or patients’ intolerances. Some questioned the benefits of medical secondary prevention for the oldest of patients.General practitioners perceived good adherence among their patients who had had an MI while they regarded their methods for assessing medical non-adherence as limited. They perceived diverse reasons for non-adherence, particularly side effects, patients’ freedom from symptoms and patients’ indifference to health. They attributed mainly negative characteristics, like lack of knowledge and understanding, to non-adherent patients. These characteristics contribute to the difficulty of convincing these patients to take medications as prescribed.General practitioners improved adherence by preventing side effects, explaining the medication’s necessity, facilitating intake and involving patients in decision-making. However, about half of the general practitioners reported threatening their patients with negative consequences of non-adherence.ConclusionsGeneral practitioners should be aware that discharge medication can be insufficient and thus, should always check hospital recommendations for accordance with guideline recommendations. Improving physicians’ communication skills and informing and motivating patients in an adequate manner, for example in simple language, should be an important goal in the hospital and the general practitioner setting. General practitioners should assess patients’ motivations through motivational interviewing, which no general practitioner mentioned during the interviews, and talk with them about adherence and long-term treatment goals regularly.

Highlights

  • An increasing prevalence of having survived a myocardial infarction increases the importance of medical secondary prevention

  • Prescribing of medication after myocardial infarction (MI) Prescribed medications The interviewed General practitioner (GP) claimed to prescribe angiotensin converting enzyme inhibitors (ACEI), betablockers, aspirin and statins for all or most patients who had had an MI, as recommended by guidelines: ‘[...] that are always ACE inhibitor or a sartan, betablocker, a statin and ASS 100 [aspirin].’ (GP2, M, BB). An exception from this was one GP who stated that he did not see any necessity for statins in patients after MI with normal lipid values

  • When the GPs were asked about a recent consultation with a patient who had had an MI, it was revealed that almost half of the interviewed GPs had not prescribed one or two of the recommended drugs in the respective case

Read more

Summary

Introduction

An increasing prevalence of having survived a myocardial infarction increases the importance of medical secondary prevention. Preventive medication reduces mortality, prescribing and adherence are known to be frequently insufficient. General practitioners are the most important prescriber. Their perspective on prescribing and medical non-adherence following myocardial infarction has not yet been explored. The aim of this study was to explore the general practitioners’ perspective on long-term care after myocardial infarction focussing on medical prevention. According to current guidelines for both ST-elevation myocardial infarction (STEMI) [7, 8] and non-ST-elevation myocardial infarction (NSTEMI) [9, 10], aspirin and statins are recommended and beta-blockers and angiotensin converting enzyme inhibitors (ACEI) should be considered, each unless there are contraindications. P2Y12 inhibitors for dual antiplatelet therapy (DAPT) are usually recommended for twelve months [7,8,9,10]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.